Circulating miR-27a as a non-invasive diagnostic biomarker to differentiate malignant from benign breast lesions: a preliminary study
MiR27a shows strong potential to be used as a biomarker for breast cancer diagnosis and prognosis. sHER-2 effectively differentiated between the HER-2 status of breast cancer. Larger studies with follow-up are needed for clinical validation.
Authors
- M. H. Jamal
- Manpreet Kaur
- Usha Dalal (ORCID: https://orcid.org/0000-0001-9440-7490)
- Uma Handa (ORCID: https://orcid.org/0000-0002-1272-6955)
- Jasbinder Kaur (ORCID: https://orcid.org/0000-0001-9694-0213)
- Vishal Sharma (ORCID: https://orcid.org/0000-0002-2755-6100)
- Ravinder Kaur (ORCID: https://orcid.org/0000-0002-8535-6617)
- Shivani Jaswal (ORCID: https://orcid.org/0000-0002-7202-7902)
Institutions
- Government Medical College (IN)
- Government Medical College and Hospital (IN)
- Government Medical College and Hospital (IN)
Publication Details
- Journal
- Biomarkers
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1080/1354750x.2025.2568870
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00